David A. Siegel Ginkgo Bioworks Holdings, Inc. Put Options Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding DNA
# of Institutions
180Shares Held
685MCall Options Held
990KPut Options Held
2.23M-
Viking Global Investors LP143MShares$1.2 Billion0.19% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$586 Million7.28% of portfolio
-
Black Rock Inc. New York, NY42MShares$352 Million0.0% of portfolio
-
Legal & General Group PLC London, X027MShares$227 Million0.0% of portfolio
-
Glenview Capital Management, LLC New York, NY26.5MShares$222 Million0.17% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $10.8B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...